1. Executive Summary
1.1 Review of the Pharmaceutical Anti-counterfeiting Technologies Market
1.2 Aims, Scope and Format of Report
1.3 Research and Analysis Methods
2. Introduction to Drug Counterfeiting
2.1 Pharmaceutical Drug Counterfeiting
2.2 How Are Drugs Counterfeited?
2.2.1 Motivations for Drug Counterfeiting
2.2.2 Methods for Producing Counterfeit Drugs
2.2.3 Moving Counterfeit Drugs into the Supply Chain
2.2.4 The Pharmaceutical Distribution System and Corruption
2.2.5 Online Pharmacies and Drug Counterfeiting
2.2.6 Verifying the Authenticity of Online Pharmacies
2.3 The Global Costs of Drug Counterfeiting
2.3.1 The Effects of Counterfeit Drugs on Consumers
2.3.2 The Effects of Counterfeit Drugs on Manufacturers
2.3.3 The Effects of Counterfeit Drugs on Healthcare Providers
2.3.4 The Effects of Counterfeit Drugs on Governments
2.4 Drivers of Drug Counterfeiting
2.4.1 Drug Counterfeiting Thrives on the Lack of Adequate or Enforceable Legislation
2.4.2 An Erratic Supply or Shortage of Drugs Promotes Counterfeiting
2.4.3 The Inappropriate Use of Drugs Creates a Market for the Supply of Counterfeit Medicines
2.5 Action Taken by Pharmaceutical Companies in the Fight against Drug Counterfeiting
2.5.1 Introduction
2.5.2 Pfizer
2.5.3 Johnson & Johnson
2.5.4 GlaxoSmithKline
2.5.5 Sanofi-Aventis
2.5.6 Novartis
2.5.7 AstraZeneca
3. Anti-counterfeiting Technologies and Leading Manufacturers, 2011
3.1 Introduction
3.2 Major Anti-counterfeiting Technologies, 2011
3.2.1 Visual Inspection as the First Line of Defence against Drug Counterfeiting
3.2.2 Holograms as Anti-counterfeiting Technologies
3.2.3 Security Printing as an Anti-counterfeiting Technology
3.2.4 Taggants as Anti-counterfeiting Technologies
3.2.5 Radio Frequency Identification (RFID) as an Anti-counterfeiting Technology
3.3 Leading Manufacturers of Anti-counterfeiting Technologies
3.3.1 NanoGuardian
3.3.1.1 The NanoEncryption Process
3.3.1.2 NanoGuardian Closed-Loop Protection System
3.3.1.3 NanoGuardian's Global Collaboration Agreement with Capsugel
3.3.2 Ahura Scientific
3.3.2.1 Ahura Scientific's TruScan Technology
3.3.3 TruTag Technologies
3.3.3.1 TruTag's Proprietary Technology
3.3.4 Colorcon
3.3.4.1 Colorcon Brand Enhancement Service
3.3.4.2 Colorcon's Taggants: On-Dose ID
3.3.4.3 Other Identifiers by Colorcon
3.3.5 Authentix
3.3.5.1 The Brand Protection Solutions of Authentix
3.3.5.2 The Packaging Solutions of Authentix
3.3.5.3 Authentix Track-and-Trace Solutions
3.3.6 3M
3.3.6.1 The Anti-counterfeiting Solutions of 3M
3.3.7 Cortegra
3.3.7.1 Cortegra's Item-Level-Serialisation
3.3.8 Covectra
3.3.8.1 Covectra's Authenti-Track Platform
4. Summary of the Pharmaceutical Anti-counterfeiting Technologies Market, 2011-2021
4.1 Overview of the World Anti-counterfeiting Technologies Market, 2010-2021
4.2 Anti-counterfeiting Technologies Market Will See Growth in Size, 2010-2021
4.2.1 Sales of Anti-counterfeiting Technologies Will Increase in the Leading National Markets
4.2.2 RFID Market is Expected to Show Significant Growth Potential
4.3 Drug Counterfeiting Will Persist at Relatively High Levels in Developing Countries
5. Pharmaceutical Anti-counterfeiting Technologies Market, 2011-2021
5.1 The Pharmaceutical Anti-counterfeiting Technologies Market in 2010
5.2 Sales Forecast for the Global Anti-counterfeiting Technologies Market, 2010-2021
5.2.1 Government Mandates Will Promote Growth in the Anti-counterfeiting Technologies Market, 2010-2015
5.2.2 Anti-counterfeiting Technologies Market Will Continue to Grow, 2016-2021
5.3 Sales Revenues for the Leading Anti-counterfeiting Technologies, 2010-2021
5.4 Pharmaceutical RFID Market, 2010-2021
5.4.1 Pharmaceutical RFID Market, 2010
5.4.2 Pharmaceutical RFID Market, 2010-2015
5.4.3 Pharmaceutical RFID Market, 2016-2021
5.5 Pharmaceutical Taggants Market, 2010-2021
5.5.1 Pharmaceutical Taggants Market, 2010
5.5.2 Pharmaceutical Taggants Market, 2010-2015
5.5.3 Pharmaceutical Taggants Market, 2016-2021
5.6 Pharmaceutical Hologram/OVD Market, 2010-2021
5.6.1 Pharmaceutical Hologram/OVD Market, 2010
5.6.2 Pharmaceutical Hologram/OVD Market, 2010-2015
5.6.3 Pharmaceutical Hologram/OVD Market, 2016-2021
5.7 Pharmaceutical Security Inks Market, 2010-2021
5.7.1 Pharmaceutical Security Inks Market, 2010
5.7.2 Pharmaceutical Security Inks Market, 2010-2015
5.7.3 Pharmaceutical Security Inks Market, 2016-2021
5.8 Pharmaceutical Watermarks Market, 2010-2021
5.8.1 Pharmaceutical Watermarks Market, 2010
5.8.2 Pharmaceutical Watermarks Market, 2010-2015
5.8.3 Pharmaceutical Watermarks Market, 2016-2021
6. Leading National Markets for Anti-counterfeiting Technologies, 2011-2021
6.1 Percentage Share of Counterfeiting Incidents by Region, 2008
6.2 Leading National Markets for the Sale of Anti-counterfeiting Technologies, 2010
6.3 Forecasts for the Leading National Markets, 2010-2021
6.3.1 The US Anti-counterfeiting Technologies Market, 2010-2021
6.3.2 Leading European Anti-counterfeiting Technologies Markets, 2010-2021
6.3.3 The Japanese Anti-counterfeiting Technologies Market, 2010-2021
6.3.4 The Canadian Anti-counterfeiting Technologies Market, 2010-2021
6.3.5 The Chinese Anti-counterfeiting Technologies Market, 2010-2021
6.3.6 The Indian Anti-counterfeiting Technologies Market, 2010-2021
7. Analysis of the Factors Influencing the Pharmaceutical Anti-counterfeiting Technologies Market, 2011-2021
7.1 SWOT Analysis of the Pharmaceutical Anti-counterfeiting Technologies Market
7.2 Market Drivers for the Pharmaceutical Anti-counterfeiting Technologies Market
7.2.1 Public Awareness of the Scale of Drug Counterfeiting
7.2.2 Pharmaceutical Theft
7.2.3 Manufacturer and Distributor Liability for Counterfeit Products
7.2.4 New Supply Chain Security Legislation
7.3 Restraints on the Pharmaceutical Anti-counterfeiting Technologies Market
7.3.1 Lack of Industry-Wide Standards Will Impede Adoption of RFID Technology
7.3.2 Unproven Commercial Benefits of Anti-counterfeiting Technologies
7.3.2.1 Which Metrics can be Used to Prove the Commercial Benefits of Anti-counterfeiting Technologies?
7.3.3 Anti-counterfeiting Technologies to Prevent Online Fraud?
7.3.4 Maintaining Good Anti-counterfeiting Technologies Requires Investment
7.4 Outlook for the Pharmaceutical Anti-counterfeiting Technologies Market, 2011-2021
7.4.1 Prevention Alongside Detection
7.4.2 The Link between Drug Pricing and Counterfeiting
7.4.3 Parallel Trade in Europe
8. Research Interviews with Leading Experts
8.1 Interview with Katherine Eban, Investigative Journalist, Author of 'Dangerous Doses: A True Story of Cops, Counterfeiters and the Contamination of America's Drug Supply', New York, USA
8.1.1 Drug Counterfeiting and the Challenges faced by Regulators
8.1.2 Extent of Drug Counterfeiting in the USA
8.1.3 Future Challenges in Combating Drug Counterfeiting
8.1.4 The Role of Consumer Education in Combating Drug Counterfeiting
8.1.5 The Role of Technology in Combating Drug Counterfeiting
8.1.6 Outlook for the Pharmaceutical Anti-counterfeiting Market
8.1.7 Final Thoughts
8.2 Interview with Professor David Bear (Founder and Chief Medical Officer) and Steve Wood (President and CEO), Covectra, Massachusetts, USA
8.2.1 Efforts Being Made by the Pharmaceutical Industry to Secure the Drug Supply Chain
8.2.2 Key Drivers for the Global Adoption of Anti-counterfeiting Technologies
8.2.3 Barriers to an Industry-Wide Adoption of RFID Technologies
8.2.4 Covectra's Response to E-Pedigree Legislation
8.2.5 Feasibility of Adopting 2D Barcoding across the Drug Supply Chain
8.2.6 Integration of Anti-counterfeiting Technologies into Existing Production Lines
8.2.7 Covectra's Proprietary Technologies
8.3 Interview with Grace Rusi Woo, Massachusetts Institute of Technology (MIT), USA
8.3.1 The Bokode
8.3.2 Applications of the Bokode
8.3.3 Commercial Viability of the Bokode Technology and its Widespread Use
9. Outlook for the Pharmaceutical Anti-counterfeiting Technologies Market, 2011-2021
9.1 Lack of Concerted Pressure from all Stakeholders is Inadvertently Facilitating Drug Counterfeiting
9.2 Track-and-Trace Technologies Will Drive Market Growth
9.3 What Steps Can Pharmaceutical Companies take to Combat Drug Counterfeiting?
9.3.1 Greater Transparency in Reporting Cases of Drug Counterfeiting
9.3.2 Drug Pricing and the Funding of National Drug Regulatory Authorities
9.4 The Role of the International Community in Combating Drug Counterfeiting
9.4.1 Improved Inter-governmental Cooperation in Anti-counterfeiting Strategies
9.4.2 Regulatory Agencies should be Given Greater Powers
9.5 Regulating the Internet
9.6 Counterfeit Drugs from China
9.7 Some Promising Technologies for Combating Drug Counterfeiting
9.7.1 Bokode
9.7.2 SigNature DNA
9.7.3 WISeAuthentic
9.7.4 N.O.t.E.S
10. Conclusions
10.1 The World Anti-counterfeiting Technologies Market Will Experience Rapid Growth from 2010-2015
10.2 The US Will Continue to Dominate the Global Anti-counterfeiting Technologies Market
10.3 Datamatrix Labels Will Remain Competitive with RFID Tags
10.4 The Effects of Government Mandates on the Uptake of Anti-counterfeiting Technologies
10.4.1 The Situation in Developed Countries
10.4.2 The Situation in Developing Countries
List of Tables
Table 2.1 Worldwide Incidents of Drug Counterfeiting, 2002-2009
Table 3.1 Leading Anti-counterfeiting Holographic Labelling Manufacturers, 2011
Table 3.2 Leading Manufacturers of Anti-counterfeiting Security Inks, 2011
Table 3.3 Leading Manufacturers of Pharmaceutical Taggants, 2011
Table 3.4 Leading Manufacturers of RFID Tags, 2011
Table 4.1 Market Revenues ($m) and Market Shares (%) for the RFID Technology, 2011-2021
Table 5.1 Pharmaceutical Anti-counterfeiting Technologies Market ($bn), 2010-2015
Table 5.2 Pharmaceutical Anti-counterfeiting Technologies Market ($bn), 2016-2021
Table 5.3 Market Shares (%) for the Leading Anti-counterfeiting Technologies, 2010-2015
Table 5.4 Market Shares (%) for the Leading Anti-counterfeiting Technologies, 2016-2021
Table 5.5 International Patent Applications for RFID Technologies by Country of Origin (%), 2000-2010
Table 5.6 Pharmaceutical RFID Technologies Market ($m), 2010-2015
Table 5.7 Pharmaceutical RFID Technologies Market ($m), 2016-2021
Table 5.8 Pharmaceutical Taggants Market ($m), 2010-2015
Table 5.9 Pharmaceutical Taggants Market ($m), 2016-2021
Table 5.10 Pharmaceutical Hologram/OVD Market ($m), 2010-2015
Table 5.11 Pharmaceutical Hologram/OVD Market ($m), 2016-2021
Table 5.12 Pharmaceutical Security Inks Market ($m), 2010-2015
Table 5.13 Pharmaceutical Security Inks Market ($m), 2016-2021
Table 5.14 Pharmaceutical Watermarks Market ($m), 2010-2015
Table 5.15 Pharmaceutical Watermarks Market ($m), 2016-2021
Table 6.1 Sales ($m) of Anti-counterfeiting Technologies in Leading National Markets, 2010
Table 6.2 The US Anti-counterfeiting Technologies Market ($m), 2010-2015
Table 6.3 The US Anti-counterfeiting Technologies Market ($m), 2016-2021
Table 6.4 Leading National Market Shares (%) for the World Anti-counterfeiting Technologies Market, 2010-2021
Table 6.5 The European Anti-counterfeiting Technologies Market ($m), 2010-2015
Table 6.6 The European Anti-counterfeiting Technologies Market ($m), 2016-2021
Table 6.7 The Japanese Anti-counterfeiting Technologies Market ($m), 2010-2015
Table 6.8 The Japanese Anti-counterfeiting Technologies Market ($m), 2016-2021
Table 6.9 The Canadian Anti-counterfeiting Technologies Market ($m), 2010-2015
Table 6.10 The Canadian Anti-counterfeiting Technologies Market ($m), 2016-2021
Table 6.11 The Chinese Anti-counterfeiting Technologies Market ($m), 2010-2015
Table 6.12 The Chinese Anti-counterfeiting Technologies Market ($m), 2016-2021
Table 6.13 The Indian Anti-counterfeiting Technologies Market ($m), 2010-2015
Table 6.14 The Indian Anti-counterfeiting Technologies Market ($m), 2016-2021
Table 7.1 SWOT Analysis of the Pharmaceutical Anti-counterfeiting Technologies Market, 2011
Table 9.1 Pharmaceutical Anti-counterfeiting Technologies Market ($m), 2011-2021
Table 9.2 Promising Anti-counterfeiting Technologies, 2011
List of Figures
Figure 2.1 Worldwide Incidents of Drug Counterfeiting, 2002-2009
Figure 2.2 Flow Chart of the Route Taken by Counterfeit Drugs Entering the Legal Supply Chain
Figure 5.1 Pharmaceutical Anti-counterfeiting Technologies Market ($bn), 2010-2021
Figure 5.2 Market Shares (%) for the Leading Anti-counterfeiting Technologies, 2010
Figure 5.3 Market Shares (%) for the Leading Anti-counterfeiting Technologies, 2015
Figure 5.4 Market Shares (%) for the Leading Anti-counterfeiting Technologies, 2021
Figure 5.5 International Patent Applications for RFID Technologies by Country of Origin (%), 2000-2010
Figure 5.6 Pharmaceutical RFID Technologies Market ($m), 2010-2015
Figure 5.7 Pharmaceutical RFID Technologies Market ($m), 2016-2021
Figure 5.8 Pharmaceutical Taggants Market ($m), 2010-2015
Figure 5.9 Pharmaceutical Taggants Market ($m), 2016-2021
Figure 5.10 Pharmaceutical Hologram/OVD Market ($m), 2010-2015
Figure 5.11 Pharmaceutical Hologram/OVD Market ($m), 2016-2021
Figure 5.12 Pharmaceutical Security Inks Market ($m), 2010-2015
Figure 5.13 Pharmaceutical Security Inks Market ($m), 2016-2021
Figure 5.14 Pharmaceutical Watermarks Market ($m), 2010-2015
Figure 5.15 Pharmaceutical Watermarks Market ($m), 2016-2021
Figure 6.1 Sales ($m) of Anti-counterfeiting Technologies in Leading National Markets, 2010
Figure 6.2 The US Anti-counterfeiting Technologies Market ($m), 2010-2021
Figure 6.3 Leading National Market Shares (%) for the World Anti-counterfeiting Technologies Market, 2010
Figure 6.4 Leading National Market Shares (%) for the World Anti-counterfeiting Technologies Market, 2015
Figure 6.5 Leading National Market Shares (%) for the World Anti-counterfeiting Technologies Market, 2021
Figure 6.6 The European Anti-counterfeiting Technologies Market ($m), 2010-2021
Figure 6.7 The Japanese Anti-counterfeiting Technologies Market ($m), 2010-2021
Figure 6.8 The Canadian Anti-counterfeiting Technologies Market ($m), 2010-2021
Figure 6.9 The Chinese Anti-counterfeiting Technologies Market ($m), 2010-2021
Figure 6.10 The Indian Anti-counterfeiting Technologies Market ($m), 2010-2021
Figure 9.1 Pharmaceutical Anti-counterfeiting Technologies Market ($m), 2011-2021
Figure 10.1 World Anti-counterfeiting Technologies Market ($bn), 2010-2015